Literature DB >> 10088800

QT dispersion and early arrhythmic risk during acute myocardial infarction.

S Paventi1, U Bevilacqua, M A Parafati, E Di Luzio, F Rossi, P R Pelliccioni.   

Abstract

It has been suggested that QT dispersion (maximal minus minimal QT interval calculated on a standard 12-lead electrocardiogram) could reflect regional variations of ventricular repolarization and could provide a substrate for reentry ventricular arrhythmias. The present study evaluates QT dispersion in patients with acute myocardial infarction, assessing its relation with early severe ventricular arrhythmias and some clinical features. Three hundred three patients with acute myocardial infarction and a control group of 297 healthy subjects were studied. QT and QTc dispersion were determined on the electrocardiogram taken after 12 hours and on days 3 and 10 after symptoms onset and on the electrocardiogram taken in the control group. The average values of QT and QTc dispersions (ms) were as follows: 70.5 +/- 42.5-87 +/- 45.6 (12th hour), 66.7 +/- 37.6-76.8 +/- 43.6 (day 3), 68.8 +/- 42.7-76.8 +/- 42.8 (day 10), versus 43 +/- 13.2-53.9 +/- 16.2 (control group). There were statistically significant differences between QT and QTc dispersion recorded in normal subjects and in each of the three electrocardiograms taken in patients with infarction. A greater QT dispersion was recorded in patients with anterior infarction (78.9 +/- 38.5 vs 64.9 +/- 42.8 in inferior/lateral infarction). In the first 3 days QT dispersion was not different in patients treated and untreated with thrombolysis, whereas on day 10 it was greater in untreated patients (74.9 +/- 45.3 vs 60.5 +/- 37.2). Creatine kinase peak level did not influence QT dispersion. In the first 72 hours of infarction, 37 patients developed ventricular fibrillation or sustained ventricular tachycardia. Higher early values of QT and QTc dispersion were found in patients who developed severe ventricular arrhythmias (107.8 +/- 62 and 124.8 +/- 67.5 ms) than in patients without serious arrhythmias (62.9 +/- 32.2 and 80.1 +/- 37.9 ms). These data suggest that: (1) QT dispersion increased during acute myocardial infarction. (2) The values were higher in the early hours and fell late after infarction with thrombolysis. (3) Greater QT dispersion is associated with severe ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10088800     DOI: 10.1177/000331979905000305

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

1.  The immediate and short-term effect of successful percutaneous coronary intervention on repolarization in acute myocardial infarction patients.

Authors:  Dalia Giedrimiene; Satyendra Giri; C Michael White; Evaldas Giedrimas; Jeffrey Kluger
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-10       Impact factor: 1.468

2.  Heterogeneity of ventricular repolarization in newborns with severe aortic coarctation.

Authors:  Gerardo Nigro; Vincenzo Russo; Anna Rago; Andrea Antonio Papa; Nadia Della Cioppa; Federica Di Meo; Antonio Corcione; Giuseppe Caianiello; Maria Giovanna Russo; Raffaele Calabrò
Journal:  Pediatr Cardiol       Date:  2011-10-04       Impact factor: 1.655

3.  Value of the corrected QT interval dispersion obtained exercise electrocardiography in determining remote vessel disease in patients with healed Q-wave myocardial infarction.

Authors:  Bülent B Altunkeser; Kurtuluş Ozdemir; Hüseyin Ozdil; Hasan Gök; Mustafa Aydin
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

Review 4.  The heart and cardiac pacing in Steinert disease.

Authors:  Gerardo Nigro; Andrea Antonio Papa; Luisa Politano
Journal:  Acta Myol       Date:  2012-10

5.  Increased dispersion of ventricular repolarization in Emery Dreifuss muscular dystrophy patients.

Authors:  Vincenzo Russo; Anna Rago; Luisa Politano; Andrea Antonio Papa; Federica Di Meo; Maria Giovanna Russo; Paolo Golino; Raffaele Calabrò; Gerardo Nigro
Journal:  Med Sci Monit       Date:  2012-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.